VERRICA PHARMACEUTICALS INC's ticker is VRCA and the CUSIP is 92511W108. A total of 54 filers reported holding VERRICA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $35 | -63.2% | 9,123 | -44.4% | 0.00% | – |
Q2 2023 | $95 | – | 16,400 | +12712.5% | 0.00% | – |
Q2 2022 | $0 | -100.0% | 128 | -98.4% | 0.00% | – |
Q1 2022 | $67,000 | -10.7% | 8,235 | 0.0% | 0.00% | – |
Q4 2021 | $75,000 | -27.2% | 8,235 | 0.0% | 0.00% | – |
Q3 2021 | $103,000 | +10.8% | 8,235 | +0.2% | 0.00% | – |
Q2 2021 | $93,000 | -24.4% | 8,218 | +1.4% | 0.00% | – |
Q1 2021 | $123,000 | +127.8% | 8,107 | +72.5% | 0.00% | – |
Q4 2020 | $54,000 | +50.0% | 4,700 | 0.0% | 0.00% | – |
Q3 2020 | $36,000 | -76.3% | 4,700 | -65.9% | 0.00% | – |
Q2 2020 | $152,000 | +0.7% | 13,800 | 0.0% | 0.00% | – |
Q1 2020 | $151,000 | -31.1% | 13,800 | 0.0% | 0.00% | – |
Q4 2019 | $219,000 | +7.4% | 13,800 | 0.0% | 0.00% | – |
Q3 2019 | $204,000 | +27.5% | 13,800 | 0.0% | 0.00% | – |
Q2 2019 | $160,000 | +332.4% | 13,800 | +305.9% | 0.00% | – |
Q1 2019 | $37,000 | +32.1% | 3,400 | 0.0% | 0.00% | – |
Q4 2018 | $28,000 | – | 3,400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Altium Capital Management LP | 562,954 | $8,529,000 | 2.37% |
Perceptive Advisors | 3,610,412 | $54,698,000 | 0.69% |
KNOTT DAVID M | 78,424 | $1,188,000 | 0.51% |
Monashee Investment Management LLC | 200,000 | $3,030,000 | 0.47% |
Fosun International Ltd | 282,408 | $4,279,000 | 0.34% |
Parian Global Management LP | 39,560 | $599,000 | 0.27% |
Orbimed Advisors | 1,479,733 | $22,418,000 | 0.21% |
KORNITZER CAPITAL MANAGEMENT INC /KS | 719,836 | $10,906,000 | 0.18% |
SteelPeak Wealth, LLC | 132,961 | $2,014,000 | 0.16% |
Pinz Capital Management, LP | 13,422 | $203,000 | 0.05% |